Constellation Pharmaceuticals Initiates Clinical Development of CPI-1205, a Novel Inhibitor of EZH2, in Patients with Lymphoma Portfolio News / By admin April 28, 2015
Flexus Biosciences Announces Closing of its Acquisition by Bristol-Myers Squibb Portfolio News / By admin April 8, 2015
